CZ20011671A3 - Peptidová nosná skupina pro transport - Google Patents

Peptidová nosná skupina pro transport

Info

Publication number
CZ20011671A3
CZ20011671A3 CZ20011671A CZ20011671A CZ20011671A3 CZ 20011671 A3 CZ20011671 A3 CZ 20011671A3 CZ 20011671 A CZ20011671 A CZ 20011671A CZ 20011671 A CZ20011671 A CZ 20011671A CZ 20011671 A3 CZ20011671 A3 CZ 20011671A3
Authority
CZ
Czechia
Prior art keywords
transportation
support group
peptide support
peptide
truncated forms
Prior art date
Application number
CZ20011671A
Other languages
English (en)
Inventor
M. Peter Fischer
Nikolai Zhelev
Original Assignee
Cyclacel Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9825001.2A external-priority patent/GB9825001D0/en
Priority claimed from GBGB9825000.4A external-priority patent/GB9825000D0/en
Priority claimed from GBGB9902525.6A external-priority patent/GB9902525D0/en
Priority claimed from GBGB9902522.3A external-priority patent/GB9902522D0/en
Priority claimed from GBGB9914578.1A external-priority patent/GB9914578D0/en
Application filed by Cyclacel Limited filed Critical Cyclacel Limited
Publication of CZ20011671A3 publication Critical patent/CZ20011671A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • C07K14/43581—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Details Of Aerials (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Surgical Instruments (AREA)
  • Structure Of Belt Conveyors (AREA)
  • Medicinal Preparation (AREA)
  • Aerials With Secondary Devices (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CZ20011671A 1998-11-13 1999-11-11 Peptidová nosná skupina pro transport CZ20011671A3 (cs)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9825001.2A GB9825001D0 (en) 1998-11-13 1998-11-13 A delivery vector
GBGB9825000.4A GB9825000D0 (en) 1998-11-13 1998-11-13 A delivery vector
GBGB9902525.6A GB9902525D0 (en) 1999-02-04 1999-02-04 Translocation vectors
GBGB9902522.3A GB9902522D0 (en) 1999-02-04 1999-02-04 Truncated vectors
GBGB9914578.1A GB9914578D0 (en) 1999-06-22 1999-06-22 Truncated vetors

Publications (1)

Publication Number Publication Date
CZ20011671A3 true CZ20011671A3 (cs) 2001-10-17

Family

ID=27517480

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011671A CZ20011671A3 (cs) 1998-11-13 1999-11-11 Peptidová nosná skupina pro transport

Country Status (13)

Country Link
US (2) US7153931B1 (cs)
EP (2) EP1135410B1 (cs)
JP (1) JP2002530059A (cs)
AT (1) ATE419273T1 (cs)
AU (1) AU766489B2 (cs)
CA (1) CA2350919A1 (cs)
CZ (1) CZ20011671A3 (cs)
DE (1) DE69940215D1 (cs)
ES (1) ES2318906T3 (cs)
GB (1) GB2346616B (cs)
HU (1) HUP0204199A3 (cs)
IL (1) IL142869A0 (cs)
WO (1) WO2000029427A2 (cs)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786397B1 (fr) * 1998-11-30 2003-01-10 Synt Em Vecteurs peptidiques de substances a travers la barriere hematoencephalique pour etre utilises dans le diagnostic ou la therapie d'une affection du snc
US6372494B1 (en) 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6864355B1 (en) 2000-05-02 2005-03-08 Yale University Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
US8128922B2 (en) * 1999-10-20 2012-03-06 Johns Hopkins University Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
US7049395B2 (en) 2000-05-02 2006-05-23 Yale University Anti-inflammatory compounds and uses thereof
GB0012528D0 (en) * 2000-05-23 2000-07-12 Univ Palackeho Triterpenoid derivatives
DE10027777A1 (de) * 2000-06-07 2001-12-13 Otogene Ag Transfektionsverfahren
FR2816845B1 (fr) 2000-11-20 2006-10-20 Centre Nat Rech Scient Vecteurs de transport a travers un epithelium a jonctions serrees
NZ530481A (en) * 2001-06-07 2007-11-30 Skinmedica Inc Compositions comprising cell culture medium conditioned by cells grown in three-dimensional culture
DE10128832A1 (de) * 2001-06-15 2003-02-06 Jochen Reis Vektor und dessen Verwendung in gentherapeutischen Verfahren
JP2005525998A (ja) * 2001-08-30 2005-09-02 プラエシス ファーマシューティカルズ インコーポレーテッド 炎症性疾患の治療のための方法および組成物
WO2003064614A2 (en) * 2002-01-30 2003-08-07 Yale University Transport peptides and uses therefor
EP1354953A1 (en) * 2002-04-17 2003-10-22 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Smac-peptides as therapeutics against cancer and autoimmune diseases
EP1354952A1 (en) * 2002-04-17 2003-10-22 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Smac-peptides as therapeutics against cancer and autoimmune diseases
EP1495124A2 (en) * 2002-04-17 2005-01-12 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Smac-peptides as therapeutics against cancer and autoimmune diseases
US20060178297A1 (en) * 2003-01-28 2006-08-10 Troy Carol M Systems and methods for silencing expression of a gene in a cell and uses thereof
DK1589993T3 (en) 2003-01-31 2015-03-09 Sinai School Medicine COMBINATION THERAPY FOR TREATMENT OF PROTEIN FAILURE DISORDERS
WO2004076634A2 (en) 2003-02-24 2004-09-10 Ira Sanders Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease
EP1618129A2 (en) * 2003-04-30 2006-01-25 Applied Research Systems ARS Holding N.V. Beta-amyloid inhibitors and use thereof
EP1644048B1 (en) 2003-05-05 2015-04-29 Johns Hopkins University Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
GB0311576D0 (en) * 2003-05-20 2003-06-25 Inst Of Ophthalomology Anti-inflammatory agents
WO2004112728A2 (en) 2003-06-19 2004-12-29 Mount Sinai School Of Medicine Of New York University Methods and agents for treating axonal damage, inhibition of neurotransmitter release and pain transmission, and blocking calcium influx in neurons
US7342114B2 (en) 2003-07-01 2008-03-11 California Pacific Medical Center Podophyllotoxin derivatives
CA2539132A1 (en) * 2003-09-16 2005-03-24 Garvan Institute Of Medical Research Methods for identifying modulators of protein kinase c-epsilon (pkc.epsilon.) and method of treatment of aberrant glucose metabolism associated therewith
US20050148534A1 (en) * 2003-09-22 2005-07-07 Castellino Angelo J. Small molecule compositions and methods for increasing drug efficiency using compositions thereof
EP1809291A4 (en) * 2004-11-03 2012-04-04 Forhumantech Co Ltd PHARMACEUTICAL COMPOSITIONS FOR TRANSDERMAL LEVY
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
RU2470666C2 (ru) 2008-02-28 2012-12-27 Торэй Индастриз, Инк. Фармацевтическая композиция для трансназального введения
US8575305B2 (en) * 2008-06-04 2013-11-05 Medical Research Council Cell penetrating peptides
CA2737040C (en) 2008-09-19 2017-05-02 Nektar Therapeutics Polymer conjugates of therapeutic peptides
FR2941230B1 (fr) * 2009-01-19 2011-03-18 Centre Nat Rech Scient Polypeptides d'adressage specifique a des cellules-cibles d'otx2
WO2010099401A1 (en) * 2009-02-26 2010-09-02 The Board Of Trustees Of The Leland Stanford Junior University Calcium signaling modulators involving stim and orai proteins
CN102428096B (zh) * 2009-05-20 2015-03-25 东丽株式会社 细胞膜通透性肽
US20100322957A1 (en) * 2009-05-22 2010-12-23 Aderem Alan A Secretion-related bacterial proteins for nlrc4 stimulation
GB201001602D0 (en) 2010-02-01 2010-03-17 Cytovation As Oligopeptidic compounds and uses therof
JP5757497B2 (ja) * 2010-10-06 2015-07-29 公立大学法人大阪府立大学 シガトキシン類ｃｔｘ１ｂおよび５４−デオキシ−ｃｔｘ１ｂを認識するモノクローナル抗体およびそれを用いるシガトキシン類検出キット
CA2834365A1 (en) 2011-04-28 2012-11-01 Sandia Corporation Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
IN2014MN00357A (cs) 2011-08-30 2015-06-19 Medical Res Council
GB201318954D0 (en) 2013-10-28 2013-12-11 Cupid Peptide Company Ltd Cell transport
GB201507722D0 (en) 2015-05-06 2015-06-17 Norwegian Univ Sci & Tech Ntnu Anti-bacterial agents and their use in therapy
JP6550538B2 (ja) 2015-10-27 2019-07-24 カリフォルニア パシフィック メディカル センター ポドフィロトキシン誘導体およびそれらの使用
US10087194B2 (en) 2015-10-27 2018-10-02 California Pacific Medical Center Podophyllotoxin derivatives and their use
US11672866B2 (en) 2016-01-08 2023-06-13 Paul N. DURFEE Osteotropic nanoparticles for prevention or treatment of bone metastases
WO2018029256A1 (en) 2016-08-09 2018-02-15 Aarhus Universitet Modulation of ifi16 and sting activity
BR112019004203A2 (pt) * 2016-09-02 2019-06-25 Univ Illinois construto, composição farmacêutica, e, métodos para inibir angiogênese e para tratar uma doença ou enfermidade em um indivíduo distinguido por vascularização excessiva.
US11344629B2 (en) 2017-03-01 2022-05-31 Charles Jeffrey Brinker Active targeting of cells by monosized protocells
JP7495230B2 (ja) 2017-04-28 2024-06-04 オークランド ユニサービシズ リミテッド 処置方法および新規構築物
WO2020068798A1 (en) 2018-09-24 2020-04-02 Guo Jimin Living mammalian cells modified with functional modular nanoparticles
JP7489319B2 (ja) 2018-09-26 2024-05-23 株式会社カネカ 細胞膜透過性ペプチド
WO2020176716A1 (en) 2019-02-28 2020-09-03 Brinker C Jeffrey Modular metal–organic polyhedra superassembly compositions
GB201915454D0 (en) 2019-10-24 2019-12-11 Norwegian Univ Sci & Tech Ntnu Antibacterial bone cement and uses thereof
GB202006699D0 (en) 2020-05-06 2020-06-17 Therapim Pty Ltd Dosage regimen
GB202008888D0 (en) 2020-06-11 2020-07-29 Norwegian Univ Of Science And Technology (Ntnu) Peptides for sepsis treatment

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847240A (en) 1978-01-16 1989-07-11 The Trustees Of Boston University Method of effecting cellular uptake of molecules
US5043329A (en) 1987-02-17 1991-08-27 Board Of Regents, University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
DE3836971C1 (cs) 1988-10-31 1990-05-17 Weck, Wolfgang, Dr.Med., 6990 Bad Mergentheim, De
FR2662698A1 (fr) 1990-06-05 1991-12-06 Centre Nat Rech Scient Nouveaux facteurs de croissance neurotropes comprenant un peptide homeoboite.
US5888762A (en) 1990-06-05 1999-03-30 Centre National De La Recherche Scientifique (Cnrs) Neurotropic growth factors comprising a homeobox peptide
ATE154609T1 (de) 1990-10-15 1997-07-15 Tecnogen Scpa Nicht-lineare peptide, die hydropatisch komplementär zu bekannten aminosäuresequenzen sind, verfahren zur herstellung und verwendung davon
US5580563A (en) 1992-05-01 1996-12-03 Tam; James P. Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof
US5674977A (en) 1993-02-05 1997-10-07 The Ontario Cancer Institute Branched synthetic peptide conjugate
US5807746A (en) * 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
FR2739621B1 (fr) * 1995-10-05 1997-12-05 Centre Nat Rech Scient Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
US5843903A (en) 1995-11-27 1998-12-01 The Administrators Of The Tulane Educational Fund Targeted cytotoxic anthracycline analogs
US6344436B1 (en) * 1996-01-08 2002-02-05 Baylor College Of Medicine Lipophilic peptides for macromolecule delivery
US5877282A (en) * 1996-09-20 1999-03-02 Bristol-Myers Squibb Company Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
CA2264227A1 (en) 1996-09-27 1998-04-02 Raymond A. Firestone Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells
WO1998020887A1 (en) * 1996-11-14 1998-05-22 Brigham And Women's Hospital, Inc. Polyphosphoinositide binding peptides for intracellular drug delivery
US5929042A (en) 1997-03-03 1999-07-27 The Trustees Of Columbia University In The City Of New York Antisense compounds which prevent cell death and uses thereof
IT1291649B1 (it) * 1997-04-24 1999-01-19 Intercos Italiana Polveri cosmetiche rivestite con ingredienti naturali
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
AU741546B2 (en) * 1997-07-24 2001-12-06 Perseptive Biosystems, Inc. Conjugates of transporter peptides and nucleic acid analogs, and their use
JP2001513987A (ja) * 1997-08-22 2001-09-11 ワシントン大学 誘導性制御システムおよびその使用
GB9718609D0 (en) * 1997-09-02 1997-11-05 Imp College Innovations Ltd Fusion protein
WO1999045127A2 (en) * 1998-03-06 1999-09-10 Oxford Biomedica (Uk) Limited Enhanced prodrug activation
EP1086126A1 (en) * 1998-06-10 2001-03-28 The Queen's University of Belfast Cell-permeable peptide
GB9812675D0 (en) 1998-06-11 1998-08-12 Univ Edinburgh Peptides
GB9814527D0 (en) 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system

Also Published As

Publication number Publication date
WO2000029427A3 (en) 2000-10-05
IL142869A0 (en) 2002-03-10
US7101967B2 (en) 2006-09-05
ATE419273T1 (de) 2009-01-15
ES2318906T3 (es) 2009-05-01
AU766489B2 (en) 2003-10-16
EP1135410A2 (en) 2001-09-26
GB9926719D0 (en) 2000-01-12
EP1958961A3 (en) 2008-09-03
US20020098236A1 (en) 2002-07-25
WO2000029427A2 (en) 2000-05-25
EP1958961A2 (en) 2008-08-20
GB2346616A (en) 2000-08-16
GB2346616B (en) 2004-04-21
HUP0204199A2 (hu) 2003-03-28
US7153931B1 (en) 2006-12-26
EP1135410B1 (en) 2008-12-31
HUP0204199A3 (en) 2005-09-28
DE69940215D1 (de) 2009-02-12
CA2350919A1 (en) 2000-05-25
AU1063000A (en) 2000-06-05
JP2002530059A (ja) 2002-09-17

Similar Documents

Publication Publication Date Title
CZ20011671A3 (cs) Peptidová nosná skupina pro transport
IL128829A0 (en) Improved solid-phase peptide and agent for use in such synthesis
TR199900666T2 (xx) �nsan paratormonu ile ilgili peptidlere kar�� antikor.
ATE368053T1 (de) Antimikrobielle peptide
ATE460429T1 (de) Polypeptide enthaltend extrazellulären domäne von il-20ra und/oderr il-20rb
BR9914519A (pt) Peptìdios bioativos estabilizados e métodos de identificação, sìntese e uso
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
IL113617A0 (en) Soluble polypeptide fraction
PT1144607E (pt) Novos métodos para apresentar (poli)peptídeos/ proteínas em partículas bacteriofágicas através de ligações dissulfureto
BR0205983A (pt) fármacos peptìdicos antiangiogênicos
FI961044A0 (fi) Kininogeeni-inhibiittorit
GB9606040D0 (en) Active peptide
EP0820295A4 (en) MODIFIED ARGININE OR LYSINE CONTAINING PROTEINS AND PEPTIDES
IL115381A (en) Polypeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
EP0954527A4 (en) GLYCIN CONVEYOR AND TRANSFECTED CELLS AND USES THEREOF
DE69333952D1 (de) Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen.
DE69932834D1 (de) Chi-Conotoxinpeptide als Inhibitoren neuronaler Amintransporter
EP1859805A3 (en) Peptides and peptide analogues designed from the HFE protein and their uses in the treatment of iron overload diseases
ATE315646T1 (de) Leukocyten-aktivierender faktor
CA2254835A1 (en) Glycine transporter-transfected cells and uses thereof
HUP9902937A2 (hu) Rheumatoid artritisz patogenezisében szerepet játszó artritogén peptidekkel szemben immunvédettséget kiváltó vakcinakészítmények és eljárás ilyen védettség létrehozására